Inflationary storm clouds will continue to buffet global pharma industry in 2023
Pharmaceutical Technology
JANUARY 16, 2023
The legislation contains several provisions to lower prescription drug costs, including allowing Medicare to negotiate the cost of selected medicines. A worst-case scenario could also involve some pharmaceutical production in China being diverted to domestic use in early 2023. Free Report.
Let's personalize your content